Ischaemic preconditioning (IPC) is an adaptive mechanism that renders the myocardium resistant to injury from subsequent hypoxia. Although reactive oxygen species (ROS) contribute to both the early and late phases of IPC, their enzymatic source and associated signalling events have not yet been understood completely. Our objective was to investigate the role of the Nox1 NADPH oxidase in cardioprotection provided by IPC.
Introduction
Morbidity and mortality associated with myocardial infarction, the leading cause of death in developed countries, correlate with the size of the infarct. 1 Current approaches to reducing myocardial infarct size utilize reperfusion to restore blood flow or pharmacological therapies to decrease neurohumoral activation and energy requirements. However, activation of endogenous cardioprotective pathways represents an alternative strategy to reduce infarct size. Myocardial ischaemic preconditioning (IPC) provides a sublethal period of ischaemia to induce cardiac tolerance to subsequent ischaemia. 2, 3 IPC has two distinct phases: an early phase that develops within minutes and lasts 2-3 h, and a late phase that develops after 12 h and is sustained for 3 -4 days. 2, 4, 5 Understanding the mechanisms of IPC may allow targeted manipulation of these endogenous pathways and thereby provide clinical protection for patients with ischaemic heart disease.
Several factors, including reactive oxygen species (ROS), have been implicated in the distinct mechanisms by which early and late IPC provide cardioprotection. 2,3,6 -11 Redox-dependent signalling events in the early phase tend to converge on protection of the mitochondria, 3 whereas cardioprotection afforded by late IPC is mediated, in part, by redox-dependent activation of transcription factors, such as nuclear factor-kB (NF-kB). 7, 12 In addition, ROS are required for the induction of late IPC by the pro-inflammatory cytokine tumour necrosis factor (TNF)-a. 13 We and others have reported that cytokine-mediated activation of NF-kB is dependent on ROS generated by NADPH oxidases (Nox). 14, 15 Although multiple Nox isoforms are differentially expressed in the heart, 16 to date only Nox2 has been implicated in the protection afforded by early IPC. 17 Our objective in this study was to examine whether Nox1 is required for the protective effects of IPC against myocardial injury. Despite the relatively low expression of Nox1 in normal hearts, our data demonstrate that Nox1 was induced by IPC. While Nox1 was not required for protection associated with early IPC, we found that Nox1 was necessary for the protective effect of late IPC in a mechanism that included activation of NF-kB and expression of TNF-a.
Methods

IPC experimental procedure
Animal experiments were performed according to the protocol approved by the University of Iowa Institutional Animal Care and Use Committee. Studies conformed to the 'Guide for the Care and Use of Laboratory Animals' published by the US National Institutes of Health (NIH Publication
No. 85-23, revised 1996). All mice were on the C57Bl6/J background and backcrossed .10 generations. Nox1 homozygous knockout (Nox1 2/y ) and wild-type (WT) littermate male mice 18 at 9 -12 weeks of age were randomized to both early IPC ('early IPC') and late IPC ('late IPC') groups with various experimental protocols ( Figure 1 ). Mice were preconditioned with three cycles of 4 min coronary artery occlusion and 4 min reperfusion. Mice in the early IPC group were then subject to 30 min of coronary artery occlusion ( Figure 1A) ; mice in the late IPC group were allowed to recover for 24 h prior to being subjected to 30 min coronary occlusion ( Figure 1B) . Mice subjected to 30 min coronary occlusion without IPC served as controls ('sham'). Mice were anaesthetized with sodium pentobarbital (50 mg/kg, i.p.), intubated, and ventilated with room air using a TOPO TM Volume/Pressure Small Figure 1 Nox1 is necessary for the effect of late but not early IPC on infarct size reduction. Representative images and summary data of TTC-stained myocardium after early (A) or late (B) IPC. Distance between hatch marks within images ¼ 1 mm. Infarct size is presented at the percentage of total area. Occl, occlusion; Rep, reperfusion. n ¼ 6 -14; *P , 0.05 vs. sham, D P , 0.05 vs. WT late IPC.
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Animal Ventilator (Kent Scientific). A left thoracotomy was performed, the heart exposed, and the pericardium removed. A suture was passed underneath the left anterior descending (LAD) branch of the coronary artery 2 -3 mm from the tip of the left atrium along the anterolateral border of the heart. A 2 -3 mm section of PE-10 tubing was placed on top of the vessel and a surgical knot tied on top of the tubing to occlude the coronary artery. Successful ligation of the artery was confirmed by blanching of the myocardium. After occlusion for 4 min, reperfusion was allowed by loosening of the knot and removal of the PE-10 tube. After 4 min reperfusion, the PE-10 tube was again tightened against the LAD. This process was repeated three times. At the end of the procedure, a chest tube (28G, venal catheter) was placed between the fourth and the fifth ribs and then the chest wall was closed. The control group had a similar procedure with the passage of a suture under the LAD but without occlusion. For the early IPC group, after 4 min reperfusion, the mice were immediately subjected to 30 min occlusion. For the late IPC group, buprenorphine (0.1 mg/kg, s.c.) was administered immediately post-procedure and 12 h later; 24 h after reperfusion, mice were anaesthetized with sodium pentobarbital (50 mg/kg, i.p.), intubated, ventilated, and the same thoracotomy performed. A suture was passed underneath the previous site of the LAD and PE-10 tube placed on top of the vessel and tightened to occlude the coronary artery. After 30 min occlusion, the PE tube was removed to allow reperfusion, and then the chest and skin closed as above. Mice were euthanized with sodium pentobarbital (150 mg/kg, i.p.).
Cardiomyocyte culture and hypoxia preconditioning
Mice and rats were sacrificed by barbiturate overdose (pentobarbital, 150 mg/kg, i.p.). Neonatal mouse cardiomyocytes were isolated from WT mice on postnatal day 1 as described. 19 Cells were preconditioned by two sets of hypoxia (15 min, 1% O 2 , 4% CO 2 , and 95% N 2 ) in a flushed Modular Incubator Chamber (Billumps-Rothenberg) housed within a standard cell culture incubator followed by reoxygenation (30 min, 21% O 2 ) prior to a hypoxic challenge 24 h later. For studies in adult cardiomyocytes, myocytes were isolated from rats and cultured as previously described 20 for 16 h, and then treated with 10 mmol/L of TNF-a for 4 h prior to assessment of Nox1 mRNA levels.
Assessment of infarct size and risk area
To calculate ischaemic risk area, mice were subjected to LAD ligation immediately followed by injection of 1% Evans blue (w/v) into the aorta. After 30 min, mice were euthanized as above and hearts harvested and sectioned from apex to base into five transverse slices of approximately equal thickness ( 2 mm). Risk area was determined by morphometry (NIH Image J) and calculated as the percentage of the total area. Following 24 h after the prolonged coronary occlusion, myocardial infarct size was assessed by triphenyl-tetrazolium chloride (TTC) staining. Briefly, the heart was perfused with phosphate buffered saline (PBS) and then cut from apex to base into five transverse slices of approximately equal thickness ( 2 mm). The slices were placed into a small culture dish and incubated in 2% TTC at 378C for 30 min, then the buffer replaced by 10% formaldehyde for 1 h. Infarct area was determined by morphometry (NIH Image J). The infarct size was calculated as the percentage of the total area.
Echocardiographic measurements
Transthoracic echocardiograms were performed in the University of Iowa Cardiology Animal Phenotyping Core Laboratory using a Sonos 5500 Imager (Phillips Medical Systems, Bothell, WA, USA) prior to sacrificing the mice. Conscious sedation was achieved with midazolam (0.2 -0.3 mg, s.c.). The anterior chest was shaved and prewarmed ultrasonic gel applied. Two-dimensional images were acquired in left ventricular (LV) short-and long-axis planes with a 15 MHz linear-array probe, yielding .100 frames per second. LV end-diastolic volume, end-systolic volume, and ejection fraction (EF) were calculated using the bi-plane area-length method. 21 Control mice were not subjected to any surgical procedure. To calculate the ischaemic zone, regions demonstrating akinesis or dyskinesis were visually identified and planimetered. The ischaemic zone is expressed as the percentage of the total LV end-diastolic silhouette.
Nox1 silencing
Isolated cultured cardiomyocytes were transfected with recombinant adenoviruses encoding shRNA against Nox1 (Ad-shNox1, a gift from Dr Robin Davisson, Cornell University) or Ad-shGFP at Day 3 after isolation. Experiments were performed 24 -48 h post-infection. Adenoviruses were generated by the University of Iowa Gene Transfer Vector Core facility.
TUNEL staining
Paraffin-embedded myocardial sections (5 mm) or cultured cardiomyocytes fixed with 4% paraformaldehyde were stained with terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) using the In Situ Cell Death Detection Kit, TMR red (Roche) per manufacturer's instructions.
Cell viability
Cell viability was assessed with the CellTiter-Glo Luminescent Cell Viability Assay Kit (Promega) per manufacturer's instructions.
Real-time PCR
Mice were sacrificed 24 h after preconditioning with CO 2 and hearts perfused with PBS. RNA was isolated from the LV ischaemic and non-ischaemic regions with Tri-Reagent (Molecular Research Center). For cultured cardiomyocytes, cells were lysed with Tri-Reagent 4 h after treatment with TNF-a. The relative copy number of Nox1, Nox2, Nox4, and TNF-a was determined using the QuantiTect SYBR green PCR kit (Qiagen) and the ABI Prism 7000 (Applied Biosystems) detection system as previously described. 22 RNA levels were normalized to TATA box-binding protein mRNA expression.
Western blotting
Frozen hearts were homogenized in lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 10 mM NaF, 1 mM Na 3 VO 4 , 5 mM EGTA, 5 mM EDTA, 0.5% Triton X-100, 0.5% Na deoxycholate, and 0.1% SDS), containing protease inhibitors (Sigma, P8340). Tissue lysates were then centrifuged at 12 000 g for 10 min to remove insoluble debris. Protein concentrations were determined using the Pierce BCA assay (Pierce, Thermo Scientific). Samples (20 mg) were separated by SDS -PAGE and transferred to polyvinylidene fluoride membranes. Primary antibodies were Nox1 (Sigma, #SAB2501686), Nox2 (BD Transduction Laboratory, #610420), Nox4 (Santa Cruz, #sc-21860), TNF-a (Abcam, ab1793), cleaved poly (ADP-ribose) polymerase (PARP; Cell Signaling, #9548), phospho-p65 (Cell Signaling, #S536), and GAPDH (Cell Signaling, #2118). Horseradish peroxidase (HRP)-linked anti-goat IgG (1 : 5000) and anti-rabbit IgG (1 : 10000) were used to visualize bound primary antibodies with the Super Signal chemiluminescence substrate (Pierce, Thermo Scientific). Analysis was performed by scanning densitometry and processing with the Adobe Photoshop software. Signal intensity was quantitated using NIH Image J.
Immunohistochemistry
Paraffin-embedded myocardial sections (5 mm) fixed with 4% paraformaldehyde were rehydrated, followed by antigen retrieval in 10 mM sodium citrate buffer (pH 6.0), blocking in 5% milk, and incubation with anti-Nox1 antibody overnight at 48C and HRP-conjugated anti-goat secondary antibody for 1 h at room temperature. The peroxide signal was visualized by diaminobenzidine (DAB) staining (D4418, Sigma) and counterstained with Mayer's haematoxylin (MHS, Sigma). Images were obtained from the ischaemic risk area.
Nox1 in late preconditioning 2.11 NF-kB activation NF-kB electrophoretic mobility shift assay (EMSA) was performed on nuclear extracts from LV tissue using the LightShift Chemiluminescent EMSA kit (Pierce) per manufacturer's instructions. Briefly, nuclear extracts were incubated with biotin-labelled double-stranded DNA (5 ′ -AGT TGA GGG GAC TTT AGG C-3 ′ ), which contains a putative binding site for NF-kB. Following binding, an excess of unlabelled double-stranded oligonucleotide was added to the reaction mixture. DNA -protein complexes were subjected to SDS-PAGE, transferred to a nylon membrane, and exposed to film after incubation with a luminol/enhancer solution (Pierce) as described by the manufacturer. Signal intensity was quantified by densitometry (Adobe Photoshop) and expressed relative to levels in WT sham. Activation of NF-kB in paraffin-embedded myocardial sections (5 mm) was determined 24 h following the IPC or sham procedure by immunohistochemistry using anti-phospho-p65 according to the manufacturer's protocol (Cell Signaling, #S536), and sections were counterstained with haematoxylin. In separate experiments, whole heart lysates were subjected to western blotting using the phospho-p65 antibody as described above.
In isolated cultured neonatal cardiomyocytes, NF-kB-mediated transcriptional induction was measured with replication-deficient adenovirus containing the luciferase reporter gene driven by NF-kB transcriptional activation as previously described. 22, 23 Cardiomyocytes were first infected with Ad-shNox1 or Ad-shGFP after 3 days in culture, and 24 h later co-infected with Ad-NF-kB luciferase reporter gene and Ad-Renilla control (provided by the University of Iowa Gene Transfer Vector Core). Twenty-four hours later, cells were treated with TNF-a (10 mmol/L) for 6 h, and luciferase activity measured with the Dual-Luciferase Reporter Assay System (Promega). Results were expressed as a ratio between the firefly and Renilla luciferase.
Serum TNF-a
After IPC and prior to prolonged occlusion, blood was collected retroorbitally either 30 min or 24 h after the procedure. For the 24-h time point, animals were anaesthetized using 25% O 2 and 75% CO 2 . Serum was collected by incubation at room temperature for 2 h followed by centrifugation 500 g for 10 min. Serum TNF-a levels were measured with the TNF-a ELISpot kit (EL410, R&D Systems) per manufacturer's instructions.
Statistics
Data were expressed as mean + SE. Comparisons between two groups were made using the unpaired two-tailed t-test and between multiple groups using the ordinary two-way analysis of variance (ANOVA) with Tukey's multiple comparison correction. A P-value of ,0.05 was considered statistically significant. , and ischaemic zone (IZ, E). Control mice had no coronary occlusion, and sham mice were subjected to 30 min coronary occlusion without IPC; and IPC mice had the late IPC protocol described in Figure 1B . n ¼ : 27.8 + 1.6%; P ¼ 0.59; n ¼ 18 -22). Examination of baseline characteristics revealed that deficiency of Nox1 had no effect on body weight or cardiac size or function compared with age-matched male C57BL6/J mice or WT littermate controls ( Table 1) . The ischaemic risk area was similar between WT and Nox1 2/y mice (33.1 + 1.0 vs.
32.5 + 1.2%, P ¼ 0.69; n ¼ 4). Next, we evaluated the contribution of Nox1 to the protective effect provided by early and late IPC. Early IPC consisted of three cycles of occlusion -reperfusion followed immediately by a 30-min prolonged coronary occlusion, whereas, for late IPC, 24 h elapsed between the occlusion -reperfusion cycles and the coronary occlusion ( Figure 1) . In response to early IPC, infarct size was similar in hearts from Nox1 2/y mice and WT littermate controls ( Figure 1A , WT: 11.9 + 1.2%; Nox1 2/y : 13.1 + 3.2%; P . 0.05). In contrast, late IPC failed to reduce infarct size in hearts from Nox1 2/y mice compared with WT littermates ( Figure 1B , WT: 16.6 + 1.9%; Nox1 2/y : 27.6 + 3.0%; P ,
0.05). Following prolonged coronary occlusion, the LV end-diastolic
and end-systolic volumes as measured by echocardiography were increased, and the EF was decreased in WT mice (Figure 2A-D Figure 2E ). Examination of apoptosis by TUNEL staining demonstrated that late IPC failed to protect against ischaemia-induced apoptosis in Nox1-deficient myocardium compared with WT myocardium ( Figure 3A) . Confirming these observations, PARP cleavage, a marker for apoptosis, was reduced by late IPC in WT, but not in Nox1 2/y , hearts ( Figure 3B) . Extending studies to cultured cardiomyocytes, shRNA-mediated knockdown of Nox1 abrogated the protective effect of preconditioning on hypoxia-induced apoptosis ( Figure 3C-E) . Taken together, these data identify Nox1 as the critical mediator of the protective effect of late IPC following ischaemic injury or hypoxia.
Late IPC differentially alters expression of Nox1, Nox2, and Nox4
To understand the mechanism by which Nox1 contributes to late IPC-mediated protection from myocardial injury, we next examined expression of Nox1 and its homologues at baseline and after late IPC. Measurement of mRNA in whole heart lysates showed that Nox2 had the greatest baseline expression of the Nox isoforms, followed by Nox4 and Nox1 ( Figure 4A ). Hearts from Nox1 2/y mice did not exhibit compensatory changes in Nox2 or Nox4 baseline mRNA or shGFP hypoxia/PC.
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protein levels compared with WT hearts ( Figure 4A and B) . At 24 h after late IPC and prior to prolonged occlusion, Nox1 and Nox2 mRNA ( Figure 4C ) and protein ( Figure 4D ) levels were increased compared with sham IPC. Although we did not detect a significant change in Nox4 mRNA levels in response to late IPC, Nox4 protein levels were decreased. Immunohistochemistry confirms the increased expression of Nox1 in WT, but not in Nox1
, hearts in response to late IPC ( Figure 4E ). This induction of Nox1 and its requirement for myocardial protection suggest an important role for Nox1 in the mechanism by which late IPC provides protection from myocardial injury. 
TNF-a-mediated NF-kB activation in response to late preconditioning requires Nox1
With the aim of identifying the mechanism by which Nox1 contributes to the protection associated with late IPC, we explored a known signalling event that requires Nox1. Specifically, we have previously shown in vascular smooth muscle cells (SMCs) that Nox1 is necessary for activation of the pro-inflammatory transcription factor NF-kB. 23 In addition, activation of NF-kB is recognized as a critical step in the development of late IPC. 12 Whereas late IPC increased NF-kB activity in WT hearts, we detected severely blunted NF-kB activation in Nox1 2/y hearts over sham levels ( Figure 5A ). Despite the appearance of higher basal NF-kB activation in Nox1-deficient hearts, there was no difference between WT and Nox1 2/y hearts in resting inflammatory gene expression (data not shown).The increased phosphorylation of the NF-kB p65 subunit in WT but not in Nox1 2/y myocardium and heart lysates in response to late IPC ( Figure 5B and C ) confirmed that Nox1 is required for this activation of NF-kB.
Given that TNF-a is necessary for late IPC in a mechanism that includes NF-kB activation, 24 we examined whether deficiency of Nox1 altered TNF-a expression. In response to late IPC, TNF-a mRNA and protein levels were elevated in WT, but not in Nox1
2/y , myocardium ( Figure 6A and B) . Furthermore, whereas circulating TNF-a levels were increased 24 h after preconditioning in WT mice, this increase was not observed in Nox1 2/y mice ( Figure 6C ). We confirmed that Nox1-deficient mice do not have a general defect in induction of cardiac TNF-a in response to lipopolysaccharide injection (data not shown). Our findings suggest that Nox1-derived ROS are necessary for the expression of TNF-a following late IPC. It has also been shown that the effects of TNF-a on preconditioning require ROS. 13 Accordingly, TNF-a-mediated activation of NF-kB in cultured cardiomyocytes was abrogated with knockdown of Nox1 ( Figure 6D) . These data collectively demonstrate that, in response to late IPC, Nox1 is required both for TNF-a expression and for activation of NF-kB by TNF-a. We also detected increased Nox1 mRNA expression in cultured cardiomyocytes in response to TNF-a ( Figure 6E ), suggestive of a positive feedback loop whereby Nox1 activation is required for induction of TNF-a, which then feeds back to increase Nox1 levels.
Discussion
Nox1 NADPH oxidase has been implicated in multiple vascular diseases, including hypertension, restenosis, atherosclerosis, and vascular remodelling. In contrast, its role in cardiac disease is not understood, due in part to the relatively low expression of Nox1 in cardiac tissues. However, it has recently been revealed that expression of Nox1 can be induced Nox1 in late preconditioning under pathological conditions. 25 In this study, we demonstrate that Nox1 levels increase in the myocardium following IPC. Furthermore, Nox1 is necessary for the protective effect associated with late IPC in a mechanism that includes expression of TNF-a and activation of NF-kB. These findings identify activation of Nox1 as a potential strategy to protect against myocardial injury. IPC is a biphasic phenomenon, with early and late phases that depend on distinct mechanisms. The specific pathways underlying early and late IPC are complex, with a substantial amount of research in the field. 2, 3 ROS have been consistently recognized as a key mediator in the mechanisms of IPC.
2 While mitochondria have traditionally been considered to be the source of ROS in early IPC, the Nox2 NADPH oxidase has also been shown to be required for cardioprotection. 17 With late IPC, exogenous oxidants replicate whereas antioxidants abrogate protection against cardiac injury. 26 In this study, we identify Nox1 as a key enzymatic source of ROS in late IPC. TNF-a is an obligate mediator of late IPC. Preconditioning increases myocardial TNF-a, 24 and administration of TNF-a provides preconditioning-like tolerance against infarction. 27 Moreover, deficiency of TNF-a or its receptor results in loss of cardioprotection afforded by late IPC. 24, 28 The protective effect of TNF-a is mediated in part by activation of NF-kB, 24 and accordingly, inhibition of NF-kB prevents this
cardioprotection. 12 We demonstrate here that late IPC-mediated induction of TNF-a and activation of NF-kB are lost in Nox1 2/y mice.
These findings are consistent with our previous observation that Nox1 is necessary for NF-kB activation by TNF-a. 23 Collectively, these data support a feed-forward mechanism by which TNF-a activates NF-kB via Nox1, which further increases TNF-a levels. There are multiple potential mechanisms by which Nox1 may regulate TNF-a levels, including (i) intracellular signalling responsible for NF-kB activation and subsequent transcriptional events and (ii) activation of redoxsensitive metalloproteinases involved in cleavage of surface TNF-a. Our data are unable to provide insights into the primary mechanism responsible for Nox1-dependent production of TNF-a. Future studies are necessary to resolve whether the increased TNF-a is produced by cardiomyocytes or through extra-cardiac mechanisms. Such studies may provide new insights into remote preconditioning.
We propose that the Nox1-dependent mechanism of NF-kB activation in cardiomyocytes is similar to our previous observations in SMCs. 23 TNF-a binding of its receptor results in endocytosis and co-localization with Nox1 in the endosome in SMCs and HEK293 cells. 23, 29 Subsequent activation of Nox1 generates superoxide within the endosomal compartment in a process that mandates charge neutralization. 30 We proposed that this was provided by the chloride antiporter ClC-3, which we found co-localized with Nox1 in early endosomes of SMCs.
23,30
Consistent with our findings in the Nox1-deficient mice, it has recently been shown that, in response to IPC, mice deficient in ClC-3 lack cardioprotection with late but not early IPC. 31 Future experiments are necessary to determine whether endosomal colocalization of Nox1 and ClC-3 occur with preconditioning as a mechanism of NF-kB activation. Expression of Nox1 is low in the heart, but is induced by late IPC. Multiple cell types have the potential to contribute to the measured increase in Nox1; however, the staining pattern suggests expression in cardiomyocytes. Although there are well-known concerns regarding the specificity of antibodies directed towards the Nox proteins, no staining was observed in Nox1 2/y hearts. Furthermore, consistent with previous findings, 32 we show that Nox1 expression is increased by TNF-a in isolated cardiomyocytes. We have also previously reported that changes in the extracellular redox state can induce expression of Nox1 in a mechanism that involves the activating transcription factors (ATF) and cAMP response element binding (CREB) family of transcription factors. 22 Despite low basal Nox1 levels, its induction by various stimuli may be necessary for preconditioning. Future studies are warranted to examine whether increased Nox1 expression is sufficient to mimic the cardioprotective effect of late IPC. Despite recent advances, myocardial infarction remains a leading cause of morbidity and mortality. Traditional therapies have focused on reducing injury following the onset of infarction. Understanding the mechanisms by which IPC reduces the cellular response to ischaemia may allow thedevelopment of new therapeutic interventions to improve clinical outcomes in high-risk patients. We identify for the first time the induction of Nox1 NADPH oxidase as a key mediator of late IPC. Moreover, our data provide a mechanistic link between the well-defined roles for TNF-a and NF-kB in late IPC. These findings have relevance in the preclinical development of small molecule inhibitors of Nox1 for the treatment of cardiovascular disease.
